News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kendall Keith J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Kendall Keith J (Director) has filed a Form 4 on FEMASYS INC|
Txns:
| Granted 17,000 options to buy
@ $0.64, valued at
$10.9k
|
|
| 06/16/2023 |
3
| Kendall Keith J (Director) has filed a Form 3 on FEMASYS INC |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Sold 50,000 shares
@ $5.1062, valued at
$255.3k
|
|
| 06/02/2020 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,492 shares
@ $4.87, valued at
$31.6k
Exercised 14,572 restricted stock units
@ $0 |
|
| 04/02/2020 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 99 shares
@ $2.19, valued at
$216.8
Exercised 329 restricted stock units
@ $0 |
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/26/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2019 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 14,572 shares
@ $7.79, valued at
$113.5k
Exercised 14,572 restricted stock units
@ $0 |
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2019 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,676 shares
@ $3.8, valued at
$25.4k
Exercised 14,572 restricted stock units
@ $0 |
|
| 08/20/2019 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $3.84, valued at
$7.7k
Bought 1,000 shares
@ $3.925, valued at
$3.9k
Bought 2,000 shares
@ $3.995, valued at
$8k
Bought 1,000 shares
@ $4.045, valued at
$4k
Bought 1,000 shares
@ $3.697, valued at
$3.7k
Bought 1,000 shares
@ $3.65, valued at
$3.7k
|
|
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2019 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,780 shares
@ $3.72, valued at
$25.2k
Exercised 14,572 restricted stock units
@ $0 |
|
| 04/01/2019 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 263 shares
@ $6.91, valued at
$1.8k
Exercised 329 restricted stock units
@ $0 |
|
| 03/04/2019 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 325,000 options to buy
@ $8.05, valued at
$2.6M
|
|
| 03/01/2019 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,725 shares
@ $8.05, valued at
$38k
Exercised 14,572 restricted stock units
@ $0 |
|
| 01/03/2019 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 162 shares
@ $6.3, valued at
$1k
Exercised 329 restricted stock units
@ $0 |
|
| 12/04/2018 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,177 shares
@ $8.59, valued at
$61.7k
Exercised 14,572 restricted stock units
@ $0 |
|
| 11/28/2018 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $9.87, valued at
$9.9k
|
|
| 11/26/2018 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 6,000 shares
@ $10.17, valued at
$61k
Bought 1,950 shares
@ $9.9, valued at
$19.3k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/05/2018 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,510 shares
@ $18.01, valued at
$117.2k
Exercised 14,572 restricted stock units
@ $0 |
|
| 08/17/2018 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 28,043 options to buy
@ $16.46, valued at
$461.6k
Granted 2,636 restricted stock units
@ $0 |
|
| 07/26/2018 |
4
| Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 240,165 options to buy
@ $15, valued at
$3.6M
Granted 116,576 restricted stock units
@ $0 |
|
| 07/24/2018 |
3
| Kendall Keith J (President and CEO) has filed a Form 3 on Aquestive Therapeutics, Inc. |
|
|